We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Angiopoietin-Like Protein 2 Expression in Tumor Cells Supports Tumor-Associated Macrophage-Induced Tumor Progression in Esophageal Cancer

    Background

    Tumor-associated macrophages (TAM), a major component of the tumor microenvironment, play key roles in tumor formation and progression;...

    Taichi Horino, Haruki Horiguchi, ... Yuichi Oike in Annals of Surgical Oncology
    Article 09 July 2024
  2. Correlation of microscopic tumor extension with tumor microenvironment in esophageal cancer patients

    Objective

    In the era of image-guided adaptive radiotherapy, definition of the clinical target volume (CTV) is a challenge in various solid tumors,...

    Benjamin Terfa Igbo, Christina Jentsch, ... Esther G. C. Troost in Strahlentherapie und Onkologie
    Article Open access 10 May 2024
  3. Chemokines and Their Receptors: Predictors of Therapeutic Potential in Tumor Microenvironment on Esophageal Cancer

    Esophageal carcinoma (ESCA) is an aggressive solid tumor. The 5-year survival rate for patients with ESCA is estimated to be less than 20%, mainly...

    Cong-Gai Huang, Qing Liu, ... **ao-Mei Lu in Digestive Diseases and Sciences
    Article Open access 05 April 2024
  4. Thoracoscopic enucleation of an esophageal glomus tumor in the prone position: a case report and literature review

    Background

    Glomus tumors (GT) generally occur in the skin. However, esophageal GT, an extremely rare condition, has no established standardized...

    Shigeki Matsumoto, Tomoyuki Okumura, ... Tsutomu Fujii in Surgical Case Reports
    Article Open access 28 May 2024
  5. Contrast-enhanced CT radiomics features to preoperatively identify differences between tumor and proximal tumor-adjacent and tumor-distant tissues of resectable esophageal squamous cell carcinoma

    Background

    Esophagectomy is the main treatment for esophageal squamous cell carcinoma (ESCC), and patients with histopathologically negative margins...

    Dan Gao, Bang-guo Tan, ... Tian-wu Chen in Cancer Imaging
    Article Open access 19 January 2024
  6. Definitive chemoradiotherapy induces T-cell-inflamed tumor microenvironment in unresectable locally advanced esophageal squamous cell carcinoma

    Background

    Chemoradiotherapy (CRT) modulates the tumor immune microenvironment of multiple cancer types, including esophageal cancer, which...

    Takumi Habu, Shogo Kumagai, ... Takashi Kojima in Journal of Gastroenterology
    Article 31 May 2024
  7. Tumor Burden Monitoring with Circulating Tumor DNA During Treatment in Patients with Esophageal Squamous Cell Carcinoma

    Background

    To guide appropriate treatment strategy, an accurate tumor monitoring modality that reflects tumor burden during neoadjuvant treatment is...

    Yosuke Morimoto, Satoru Matsuda, ... Yuko Kitagawa in Annals of Surgical Oncology
    Article 14 February 2023
  8. Impact of Tumor Size on Survival Outcome in Esophageal Squamous Cell Carcinoma After Esophagectomy Following Neoadjuvant Chemotherapy

    Background

    Large tumor size is a prognostic factor in esophageal squamous cell carcinoma (ESCC). However, the effect of tumor size on outcomes...

    Yasufumi Koterazawa, Taro Oshikiri, ... Yoshihiro Kakeji in Annals of Surgical Oncology
    Article 27 December 2023
  9. PD-L1-expressing cancer-associated fibroblasts induce tumor immunosuppression and contribute to poor clinical outcome in esophageal cancer

    The programmed cell death 1 protein (PD-1)/programmed cell death ligand 1 (PD-L1) axis plays a crucial role in tumor immunosuppression, while the...

    Kento Kawasaki, Kazuhiro Noma, ... Toshiyoshi Fujiwara in Cancer Immunology, Immunotherapy
    Article Open access 05 September 2023
  10. HSF1 expression in tumor-associated macrophages promotes tumor cell proliferation and indicates poor prognosis in esophageal squamous cell carcinoma

    Purpose

    Tumor-associated macrophages (TAMs), are crucial for the survival and development of tumor cells. Heat shock factor 1 (HSF1) is a potent,...

    Yiqiu Li, Qifan Li, ... Ge Zhang in Clinical and Translational Oncology
    Article 31 December 2022
  11. Required esophageal resection length beyond the tumor boundary to ensure a negative proximal margin for gastric cancer with gross esophageal invasion or esophagogastric junction cancer

    Background

    To obtain a pathologically negative proximal margin (PM) for gastric cancer with gross esophageal invasion (EI) or esophagogastric junction...

    Yasufumi Koterazawa, Manabu Ohashi, ... Souya Nunobe in Gastric Cancer
    Article 01 February 2023
  12. Decoding tumor stage by peritumoral and intratumoral radiomics in resectable esophageal squamous cell carcinoma

    Purpose

    To evaluate the potential application of radiomics in predicting Tumor-Node-Metastasis (TNM) stage in patients with resectable esophageal...

    **an-Zheng Tan, Rong Ma, ... Zai-Yi Liu in Abdominal Radiology
    Article Open access 13 October 2023
  13. Highly Expressed Z-DNA Binding Protein 1 in Esophageal Cancer Promotes Tumor Growth

    Background

    Esophageal cancer (ESCA) is a common malignant tumor of the digestive tract, and its poor prognosis is mainly attributed to the occurrence...

    Shabahaiti Wusiman, Yining Liu, ... Ling Liu in Digestive Diseases and Sciences
    Article 20 March 2024
  14. Hemothorax due to a ruptured esophageal gastrointestinal stromal tumor: case report

    Background

    Esophageal gastrointestinal stromal tumors (GISTs) are rare tumors of the gastrointestinal interstitium, and comprise less than 0.7% of all...

    Shohei Ohki, Naoki Enomoto, ... Kazuhiko Yamada in Surgical Case Reports
    Article Open access 11 August 2022
  15. Association of MARCH7 with tumor progression and T-cell infiltration in esophageal cancer

    MARCH7 is an E3 ubiquitin ligase known to regulate neuronal development,T-cell proliferation, and cell and tissue differentiation. But, the altered...

    Shivam Singh, Arjumand Bano, ... Rinu Sharma in Medical Oncology
    Article 30 December 2022
  16. Early Contrast-Enhanced MR for Diagnosing Complete Tumor Response of Locally Advanced Esophageal Squamous Cell Carcinoma After Neoadjuvant Therapy: A Retrospective Comparative Study

    Background

    This study assessed the performance of early contrast-enhanced magnetic resonance (ECE-MR) in the detecting of complete tumor response...

    Yan-Jie Shi, Shuo Yan, ... Ying-Shi Sun in Annals of Surgical Oncology
    Article 07 March 2024
  17. The area of residual tumor predicts esophageal squamous cell carcinoma prognosis following neoadjuvant chemotherapy

    Purpose

    To clarify the utility of the area of residual tumor for patients with esophageal squamous cell cancer treated with neoadjuvant chemotherapy.

    ...
    Masahiro Adachi, Naoki Aoyama, ... Shingo Sakashita in Journal of Cancer Research and Clinical Oncology
    Article 06 October 2022
  18. Early and Persistent Dysphagia Relief Predicts Tumor Response in Esophageal Squamous Cell Carcinoma Patients Treated with Immunochemotherapy

    Background

    In this prospective study, we aimed to investigate the role of patient-reported dysphagia relief in predicting pathological tumor responses...

    Shujie Huang, Yong Tang, ... Guibin Qiao in Annals of Surgical Oncology
    Article 24 April 2023
  19. Utility of Initial Tumor Reduction as a Prognostic Factor in Esophageal Squamous Cell Cancer Patients Undergoing Neoadjuvant Chemotherapy Followed by Surgery

    Background

    While a neoadjuvant chemotherapy regimen using docetaxel, cisplatin, and 5-fluorouracil (NAC-DCF) is considered the standard treatment for...

    Takaomi Hagi, Osamu Shiraishi, ... Takushi Yasuda in Annals of Surgical Oncology
    Article 25 April 2024
Did you find what you were looking for? Share feedback.